Skip to main content
Equibles

NOMURA HOLDINGS INC

Position in SMMT — Summit Therapeutics Inc.

CIK 1163653 TOKYO, M0
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,637,070
-$4,316,009 QoQ
Shares Held
112,359
-64.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#73
of 242 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Derivatives in SMMT

reported options exposure · as of Jun 30, 2026
CallValue
$1,440,973
CallShares
98,900
PutValue
$262,260
PutShares
18,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names. SMMT ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 402,192 $31,889,803
2 BBIO
BridgeBio Pharma, Inc.
 327,475 $24,390,338
3 LGND
Ligand Pharmaceuticals Inc
 61,938 $19,577,982
4 AUPH
Aurinia Pharmaceuticals Inc.
 978,602 $16,606,875
5 HRMY
Harmony Biosciences Holdings, Inc.
 417,932 $15,216,904
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 29,198 $14,503,522
7 OABI
OmniAb, Inc.
 5,028,160 $12,369,273
8 REGN
Regeneron Pharmaceuticals, Inc.
 14,320 $8,929,092

All Filings in SMMT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,637,070 112,359
2026-06-30 $262,260 18,000
2026-06-30 $1,440,973 98,900
2026-03-31 $455,040 24,000
2026-03-31 $5,953,079 313,981
2026-03-31 $1,856,184 97,900
2025-12-31 $874,500 50,000
2025-12-31 $9,483,672 542,234
2025-09-30 $1,239,600 60,000
2025-09-30 $2,272,600 110,000
2025-09-30 $21,670,831 1,048,927
2025-06-30 $1,064,000 50,000
2025-06-30 $935,383 43,956
2024-09-30 $415,377 18,967
2023-03-31 $83,949 47,971